Portfolio Design Labs, LLC Astrazeneca PLC Transaction History
Portfolio Design Labs, LLC
- $509 Billion
- Q2 2025
A detailed history of Portfolio Design Labs, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Portfolio Design Labs, LLC holds 3,431 shares of AZN stock, worth $288,409. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,431
Previous 2,757
24.45%
Holding current value
$288,409
Previous $203 Million
18.32%
% of portfolio
0.05%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,450Shares Held
498MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.37 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.46 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.64 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.62 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $261B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...